Yanyang Li
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Targeting the Nrf2-SLC7A11/GPX4 Pathway to Inhibit Ferroptosis: Mechanism of Yiqi Fumai Formula in Acute Decompensated Heart Failure.
Journal: QJM : monthly journal of the Association of Physicians
Published: March 20, 2026
Tongmai Yangxin Pill ameliorates doxorubicin-induced cardiotoxicity through m6A/ALKBH5/BNIP3 axis.
Journal: Journal of ethnopharmacology
Published: October 24, 2025
The Potential Therapeutic Prospect of PANoptosis in Heart Failure.
Journal: Journal of inflammation research
Published: August 24, 2024
A new perspective in the prevention and treatment of antitumor therapy-related cardiotoxicity: Intestinal microecology.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 02, 2023
Driving force of deteriorated cellular environment in heart failure: Metabolic remodeling.
Journal: Clinics (Sao Paulo, Brazil)
Published: January 07, 2023
Preparation and Evaluation of Animal Models of Cardiotoxicity in Antineoplastic Therapy.
Journal: Oxidative medicine and cellular longevity
Published: April 15, 2022
NLRP3 Inflammasome: a Novel Insight into Heart Failure.
Journal: Journal of cardiovascular translational research
Published: March 30, 2022
Shenmai injection improves doxorubicin cardiotoxicity via miR-30a/Beclin 1.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 17, 2020
The emerging role of circular RNAs in cardiovascular diseases.
Journal: Journal of physiology and biochemistry
Published: September 14, 2020
Last Updated: 09/26/2026